### Essential Takeaway MCNs are premalignant mucin-producing pancreatic cystic neoplasms that occur almost exclusively in women and typically arise in the pancreatic body or tail. Unlike IPMNs, MCNs **do not communicate with the pancreatic duct** and contain characteristic **[[ovarian-type stroma]]** on pathology. --- ### Key Clinical Features - Predominantly affects middle-aged women - Usually located in the pancreatic body/tail - Typically solitary - Often discovered incidentally - May present with abdominal pain, fullness, pancreatitis, or enlarging cyst > [!tip] > **Classic boards presentation:** > Middle-aged woman with a septated mucinous cystic lesion in the pancreatic tail without duct communication. --- ### Defining Features | Feature | MCN | |---|---| | Mucinous epithelium | Yes | | Ovarian-type stroma | Required for diagnosis | | Main duct communication | No | | Typical location | Body/tail | | Sex predominance | Female | | Malignant potential | Yes | --- ### Imaging Characteristics #### CT / MRI - [[Macrocystic multiloculated cyst.png|Macrocystic multiloculated cyst]] - Thick wall or septations - Usually no ductal communication - Peripheral calcification may increase concern for malignancy - Enhancing mural nodules are worrisome #### EUS Findings - Septations - Mucinous fluid - Possible mural nodules --- ### [[Cyst Fluid Analysis]] | Marker | Interpretation | | ------------ | -------------------------------------------------------------- | | Elevated CEA | Supports mucinous cyst | | Low amylase | Supports lack of duct communication | | Cytology | Limited sensitivity but may detect high-grade dysplasia/cancer | > [!info] > CEA is a marker of *mucinous differentiation* but does **not** reliably predict invasive cancer or dysplasia grade. --- ### Malignant Potential MCNs exist on a dysplasia spectrum: - Low-grade dysplasia - Intermediate-grade dysplasia - High-grade dysplasia - Invasive adenocarcinoma Features associated with malignancy: - Large size - Enhancing mural nodules - Solid component - Thickened wall - Symptoms - Peripheral calcifications --- ### Management #### Surgical Resection Generally recommended for: - Fit surgical candidates - Lesions with concerning features - Most surgically accessible body/tail lesions in healthy patients Typical operation: - Distal pancreatectomy ± splenectomy #### Surveillance May be considered selectively for: - Small asymptomatic lesions - No mural nodules or high-risk features - High operative risk patients --- ### Pathology Histologic hallmark: - **[[ovarian-type stroma]]** beneath mucinous epithelium Pathologic grading: - Low-grade dysplasia - Intermediate-grade dysplasia - High-grade dysplasia - Invasive carcinoma --- ### MCN vs [[Intraductal Papillary Mucinous Neoplasm (IPMN)#Branch-Duct IPMN|BD-IPMN]] | Feature | MCN | BD-IPMN | | ------------------- | --------- | --------------- | | Duct communication | No | Yes | | Ovarian-type stroma | Yes | No | | Typical location | Body/tail | Often head | | Multifocality | Rare | Common | | Female predominance | Strong | Less pronounced | --- ### Practice Essentials - Think: **female + body/tail + mucinous cyst without duct communication** - [[ovarian-type stroma]] defines the lesion pathologically - Presence of mural nodules or solid components escalates concern - MCNs are premalignant and frequently treated surgically in appropriate candidates - Distinguishing MCN from [[Intraductal Papillary Mucinous Neoplasm (IPMN)#Branch-Duct IPMN|branch-duct IPMN]] is a common clinical challenge